Zoetis | ZTS - Current Liabilities




Zoetis reported $3.41B in Current Liabilities for its fiscal quarter ending in December of 2024.

Current Liabilities Change Date
AbbVie USD 43.06B 1.15B Sep/2024
Align Technology USD 2.04B 25.58M Dec/2024
Bayer EUR 25.05B 6.51B Sep/2024
Bristol-Myers Squibb USD 23.77B 1.14B Dec/2024
Charles River Laboratories USD 994.1M 18.12M Dec/2024
Dentsply International USD 1.54B 219M Sep/2024
Eli Lilly USD 24.67B 2.45B Sep/2024
Henry Schein USD 2.93B 380M Sep/2024
Idexx Laboratories USD 1.07B 58.69M Dec/2024
Illumina USD 1.55B 572M Dec/2024
IQVIA Holdings USD 6.96B 35M Dec/2024
J&J USD 51.76B 2.17B Sep/2024
Laboratory Of America USD 3.33B 81.8M Dec/2024
Merck USD 29.59B 3.53B Sep/2024
Neogen USD 151.2M 28.51M Nov/2024
Pacira USD 306.4M 213.71M Sep/2024
Patterson Companies USD 1.34B 0 Oct/2024
Perrigo USD 1.45B 37.6M Sep/2024
Pfizer USD 43.21B 608M Sep/2024
Quest Diagnostics USD 2.17B 77M Dec/2024
Sanofi 30.03B 5.82B Jun/2024
Sanofi 30.03B 5.82B Jun/2024
Zoetis USD 3.41B 1.71B Dec/2024